Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period September 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 1 088 1 190 1 281 1 428 1 554 1 679
EBITDA 175 205 228 297 327 362
Operating profit (EBIT) 154 178 197 263 290 323
Pre-Tax Profit (EBT) 142 189 179 244 285 320
Net income 98,3 134 126 169 199 226
P/E ratio 28,1x 28,1x 51,4x 54,3x 46,6x 42,1x
EPS ( € ) 1,21 1,57 1,41 1,90 2,21 2,45
Dividend per Share ( € ) 0,42 0,55 0,55 0,66 0,77 0,85
Yield 1,23% 1,25% 0,76% 0,64% 0,74% 0,82%
Reference price ( € ) 34,030 44,165 72,500 103,300 103,300 103,300
Announcement Date 12/09/2016
05:19pm
12/09/2017
05:30am
12/07/2018
09:04pm
- - -
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period September 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 335 253 670 663 756 867
Operating income (EBITDA) 175 205 228 297 327 362
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 12,8 13,7 16,5 30,0 29,6 32,5
Book Value Per Share (BVPS) ( € ) 9,81 13,6 14,5 15,6 17,1 18,7
Cash Flow per Share ( € ) 1,37 0,44 2,09 2,13 2,25 2,50
Announcement Date 12/09/2016
05:19pm
12/09/2017
05:30am
12/07/2018
09:04pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 9 194 M € -
Entreprise Value (EV) 8 531 M € 8 438 M €
Valuation 2019e 2020e
P/E ratio (Price / EPS) 54,3x 46,6x
Capitalization / Revenue 6,44x 5,92x
EV / Revenue 5,97x 5,49x
EV / EBITDA 28,7x 26,1x
Yield (DPS / Price) 0,64% 0,74%
Price to book (Price / BVPS) 6,61x 6,04x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 18,4% 18,7%
Operating Leverage (Delta EBIT / Delta Sales) 2,96x 1,14x
Net Margin (Net Profit / Revenue) 11,9% 12,8%
ROA (Net Profit / Asset) 10,1% 10,5%
ROE (Net Profit / Equities) 12,6% 13,5%
Rate of Dividend 34,6% 34,6%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   2,10% 1,90%
Cash Flow / Sales 13,4% 13,0%
Capital Intensity (Assets / Sales) 1,17x 1,22x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend